These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38127218)

  • 1. ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.
    Bedrikovetski S; Traeger L; Sammour T
    Ann Surg Oncol; 2024 Mar; 31(3):1692-1693. PubMed ID: 38127218
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: When to Operate Following Neoadjuvant Therapy for Locally Advanced Rectal Cancer?
    Roxburgh CSD; Weiser MR
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):680-681. PubMed ID: 31392527
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Combining Intensive Neoadjuvant Therapy with Minimally Invasive Surgery: A Promising Future Strategy for Rectal Cancer with High-Risk Features.
    Konishi T; Shinozaki E
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):753-754. PubMed ID: 31571051
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Decline in Unnecessary Surgery by Structural Restaging After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.
    Huisman JF; de Vos Tot Nederveen Cappel WH; van Westreenen HL
    Ann Surg Oncol; 2021 Dec; 28(Suppl 3):862-863. PubMed ID: 33111246
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Addition of Induction Chemotherapy Prior to Neoadjuvant Chemo(Re)Irradiation in Patients with Locally Recurrent Rectal Cancer to Improve Long-Term Outcomes.
    Voogt ELK; Burger PWA; Rutten HJT
    Ann Surg Oncol; 2020 Sep; 27(9):3514-3515. PubMed ID: 32266570
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Prediction of Treatment Response to Neoadjuvant Chemoradiotherapy Based on a Collagen Features Model in Rectal Cancer Patients.
    Jiang W; Gao Y; Zhuo S; Yan J
    Ann Surg Oncol; 2021 Oct; 28(11):6422-6423. PubMed ID: 34047861
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone.
    Flanagan M; Clancy C; Burke J
    Ann Surg Oncol; 2021 Sep; 28(9):5250-5251. PubMed ID: 33782799
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Rectal Preservation After Major or Complete Clinical Response to Neoadjuvant Therapy-The Safety of Integrated Approaches.
    Marchegiani F; Spolverato G; Pucciarelli S
    Ann Surg Oncol; 2022 Mar; 29(3):1890-1891. PubMed ID: 34859322
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Combinations of Systemic Inflammatory Markers and CD8+ Tumor-infiltrating Lymphocyte Density: Predictive Utility for Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Sawada R; Akiyoshi T
    Ann Surg Oncol; 2021 Oct; 28(11):6199-6200. PubMed ID: 33876351
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait.
    Kim JK; Garcia-Aguilar J
    Ann Surg Oncol; 2022 Feb; 29(2):1180. PubMed ID: 34613534
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Bang for Your Buck-Implications of the Cost-Effectiveness of Watchful Waiting Versus Radical Surgery for Locally Advanced Rectal Cancer After Successful Neoadjuvant Chemoradiation.
    Cui CL; Luo WY; Cosman BC; Eisenstein S; Simpson D; Ramamoorthy S; Murphy J; Lopez NE
    Ann Surg Oncol; 2022 Mar; 29(3):1908-1909. PubMed ID: 34522995
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Local Excision Following Neoadjuvant Therapy for Rectal Cancer: A Compromise Between TME and Watch-and-Wait in Patients with Major Response.
    Bao QR; Capelli G; Spolverato G; Pucciarelli S
    Ann Surg Oncol; 2021 May; 28(5):2809-2810. PubMed ID: 33095361
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: CT-Based Radiomics Model to Predict Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T
    Ann Surg Oncol; 2020 Oct; 27(11):4284-4285. PubMed ID: 32740734
    [No Abstract]   [Full Text] [Related]  

  • 14. Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.
    Bedrikovetski S; Traeger L; Fitzsimmons T; Price TJ; Ruszkiewicz AR; Vather R; Sammour T
    Ann Surg Oncol; 2024 Mar; 31(3):1681-1689. PubMed ID: 38071720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Oncological Outcomes of Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced Rectal Cancer.
    Yamaguchi T; Akiyoshi T; Konishi T
    Ann Surg Oncol; 2023 Aug; 30(8):4725-4726. PubMed ID: 37036587
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment.
    Orlandi E; Romboli A; Citterio C; Trubini S; Vecchia S; Palladino MA; Capelli P; Cavanna L
    Anticancer Res; 2023 May; 43(5):2015-2024. PubMed ID: 37097644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
    Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
    Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.
    Chopra A; Beane JD
    Ann Surg Oncol; 2021 Nov; 28(12):7770-7771. PubMed ID: 34028634
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy.
    Oshiro T; Uehara K; Aiba T; Mukai T; Ebata T; Nagino M
    Int J Clin Oncol; 2018 Aug; 23(4):681-688. PubMed ID: 29478127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer.
    Alva-Ruiz R; Truty MJ
    Ann Surg Oncol; 2022 Mar; 29(3):1592-1593. PubMed ID: 34705142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.